Skip to main content

Advertisement

Table 4 Development and implementation costs by DMP

From: Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants

  N Development phase* Implementation year 1*
   Total costs without amortization # Costs per patient without amortization Costs per patient with amortization* Total costs without amortization # Costs per patient without amortization Costs per patient with amortization
CVR-DMP 1 300 52,136 174 35 16,426 55 90
CVR-DMP 2 207 54,417 263 53 68,415 331 381
CVR-DMP 3 700 98,754 141 28 153,215 219 234
CVR-DMP 4 300 274,783 916 183 171,026 570 605
CVR-DMP 5 550 26,807 49 10 67,604 123 142
CVR-DMP 6 450 27,923 62 12 149,990 333 356
CVR-DMP 7 125 13,324 107 21 37,968 304 387
CVR-DMP 8 250 195,007 780 156 168,385 674 715
CVR-DMP 9 1,000 26,678 27 5 81,258 81 92
COPD-DMP 1 2,508 154,504 62 12 214,239 85 90
COPD-DMP 2 1,600 93,909 59 12 49,751 31 38
COPD-DMP 3 133 49,639 373 75 55,191 415 493
COPD-DMP 4 2,400 44,586 19 4 32,599 14 18
DMII-DMP 1 2,400 5,891 2 0 28,061 12 16
DMII-DMP 2 233 162,889 699 140 387,879 1,655 1,709
DMII-DMP 3 300 50,304 168 34 61,338 204 239
  1. *We used 5 years as amortization period; #These costs are not per patient.